CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 137 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,850,000 | +401.4% | 254,885 | +348.8% | 0.00% | – |
| Q3 2016 | $369,000 | +81.8% | 56,787 | +52.9% | 0.00% | – |
| Q2 2016 | $203,000 | +33.6% | 37,135 | +14.3% | 0.00% | – |
| Q1 2016 | $152,000 | +0.7% | 32,498 | +7.4% | 0.00% | – |
| Q4 2015 | $151,000 | -4.4% | 30,248 | -28.1% | 0.00% | – |
| Q3 2015 | $158,000 | -39.2% | 42,042 | -2.7% | 0.00% | – |
| Q2 2015 | $260,000 | +21.5% | 43,210 | +13.1% | 0.00% | – |
| Q1 2015 | $214,000 | +96.3% | 38,207 | +5.6% | 0.00% | – |
| Q4 2014 | $109,000 | +6.9% | 36,186 | -4.5% | 0.00% | – |
| Q3 2014 | $102,000 | -11.3% | 37,876 | -8.0% | 0.00% | – |
| Q2 2014 | $115,000 | -41.0% | 41,171 | -8.0% | 0.00% | – |
| Q1 2014 | $195,000 | +44.4% | 44,763 | +6.5% | 0.00% | – |
| Q4 2013 | $135,000 | +114.3% | 42,018 | +6.8% | 0.00% | – |
| Q3 2013 | $63,000 | -1.6% | 39,348 | +7.1% | 0.00% | – |
| Q2 2013 | $64,000 | – | 36,734 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |